期刊文献+

mRNA-based therapeutics:powerful and versatile tools to combat diseases 被引量:3

原文传递
导出
摘要 The therapeutic use of messenger RNA(mRNA)has fueled great hope to combat a wide range of incurable diseases.Recent rapid advances in biotechnology and molecular medicine have enabled the production of almost any functional protein/peptide in the human body by introducing mRNA as a vaccine or therapeutic agent.This represents a rising precision medicine field with great promise for preventing and treating many intractable or genetic diseases.In addition,in vitro transcribed mRNA has achieved programmed production,which is more effective,faster in design and production,as well as more flexible and cost-effective than conventional approaches that may offer.Based on these extraordinary advantages,mRNA vaccines have the characteristics of the swiftest response to large-scale outbreaks of infectious diseases,such as the currently devastating pandemic COVID-19.It has always been the scientists’desire to improve the stability,immunogenicity,translation efficiency,and delivery system to achieve efficient and safe delivery of mRNA.Excitingly,these scientific dreams have gradually been realized with the rapid,amazing achievements of molecular biology,RNA technology,vaccinology,and nanotechnology.In this review,we comprehensively describe mRNA-based therapeutics,including their principles,manufacture,application,effects,and shortcomings.We also highlight the importance of mRNA optimization and delivery systems in successful mRNA therapeutics and discuss the key challenges and opportunities in developing these tools into powerful and versatile tools to combat many genetic,infectious,cancer,and other refractory diseases.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2022年第6期1975-2009,共35页 信号转导与靶向治疗(英文)
基金 supported by the Sichuan Province Science and Technology Support Program(2021YFH0003,2021YFSY008,2020YFH0065,and 2020YJ0238) the Chengdu Key S&T Innovation Projects(2019-YF08-00139-GX).
关键词 VERSATILE FASTER DREAMS
  • 相关文献

参考文献11

二级参考文献63

  • 1Dyer LA, Kirby ML. The role of secondary heart field in car- diac development. Dev Bio12009; 336:137-144.
  • 2Bussmann J, Bakkers J, Schulte-Merker S. Early endocardial morphogenesis requires Scl/Tal 1. PLoS Genet 2007; 3 :e 140.
  • 3Schoenebeck JJ, Keegan BR, Yelon D. Vessel and blood speci- fication override cardiac potential in anterior mesoderm. Dev Cell 2007; 13:254-267.
  • 4Lough J, Sugi Y. Endoderm and heart development. Dev Dyn 2000; 217:327-342.
  • 5Wei Y, Mikawa T. Fate diversity of primitive streak cells during heart field formation in ovo. Dev Dyn 2000; 219:505-513.
  • 6Milgrom-Hoffman M, Harrelson Z, Ferrara N, Zelzer E, Evans SM, Tzahor E. The heart endocardium is derived from vascular endothelial progenitors. Development 2011 ; 138:4777-4787.
  • 7Red-Horse K, Ueno H, Weissman IL, Krasnow MA. Coronary arteries form by developmental reprogramming of venous cells. Nature 2010; 464:549-553.
  • 8Wu B, Zhang Z, Lui W, et al. Endocardial cells form the coro- nary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell 2012; 151:1083-1096.
  • 9Sizarov A, Lamers WH, Mohun TJ, Brown NA, Anderson RH, Moorman AF. Three-dimensional and molecular analysis of the arterial pole of the developing human heart. JAnat 2012; 220:336-349.
  • 10Laugwitz KL, Moretti A, Lam J, et al. Postnatal isll+ cardio- blasts enter fully differentiated cardiomyocyte lineages. Nature2005; 433:647-653.

共引文献116

同被引文献19

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部